Geron Looks For Partnerships With Revised Leadership Team
This article was originally published in The Pink Sheet Daily
Executive Summary
Longtime CFO David Greenwood, who led the biotech's 1996 IPO, becomes president and interim CEO of Geron, whose human embryonic stem cell program is back on track.
You may also be interested in...
People In The News: Tracking The Latest Industry Personnel Moves
Presidents & CEOs
People In The News: Tracking The Latest Industry Personnel Moves
Presidents & CEOs
Geron Gets Green Light To Test Embryonic Stem Cell Therapy On Humans
After being delayed since May, Geron’s 21,000-page application clears overnight in the first week of the Obama administration.